Breaking News

New treatments to address meth crisis may be around the corner; pharma's latest hires and departures

   

 

Pharmalot Ed Silverman

STAT+: Humana appeases Wall Street with big projections of Medicare Advantage growth

By Bob Herman

Richard Drew/AP

During an investor day, Humana worked to appease Wall Street’s concerns that it was losing ground in the booming Medicare Advantage market.

Read More

STAT+: Intellia says CRISPR treatment safely corrects DNA of six patients with rare disease

By Megan Molteni

Ruby Wallau for STAT

The company said patients with a genetic swelling disorder had small, corrective changes made to dysfunctional DNA inside their liver cells.

Read More

The meth crisis is worse than ever, but new treatments might be around the corner

By Lev Facher

Adobe

Monoclonal antibodies are one of several promising new approaches to battling a type of addiction that had defied medication treatment.

Read More

STAT+: Up and down the ladder: The latest comings and goings

By Ed Silverman

Alex Hogan/STAT

From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.

Read More

At a fashion show for people with spinal muscular atrophy, models take back their own stories

By Matthew Herper

Courtesy IMAXTree for Genentech

The event was part of an initiative to raise awareness about the lives and needs of people with spinal muscular atrophy.

Read More

Friday, September 16, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments